OTC Markets EXMKT - Delayed Quote USD
Claritas Pharmaceuticals, Inc. (CLAZF)
0.0001
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Robert Farrell J.D. | Chairman, CEO & President | 300k | -- | -- |
| Ms. Victoria Diana Rudman | Interim CFO, Treasurer & Secretary | 75k | -- | 1968 |
| Mr. Seth Yakatan | Co-Founder | 22.5k | -- | 1970 |
| Dr. Stuart L. Silverman FACP, FACR, M.D. | Chair of Scientific Advisory Board and Vice President of Medical Affairs | -- | -- | 1947 |
| Dr. Sari Prutchi-Sagiv Ph.D. | Chief Scientific Officer | 146k | -- | -- |
| Dr. Moshe Yeshurun M.D. | Chief Medical Officer | 86k | -- | -- |
| Dr. Amos Rosenthal Ph.D. | Head of Chemistry | -- | -- | -- |
Claritas Pharmaceuticals, Inc.
4040 Civic Center Drive
Suite 200
San Rafael, CA 94903
United States
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.
Corporate Governance
Claritas Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
25I.SG ImmuPharma PLC
0.0295
0.00%
22Z.SG Zealand Pharma A/S
56.18
-6.30%
6XC.F Soleno Therapeutics, Inc.
64.85
+1.25%
688428.SS InnoCare Pharma Limited
20.56
+0.54%
BT3.BE Lineage Cell Therapeutics Inc
0.4060
+5.73%
328.SG MeiraGTx Holdings PLC
4.8400
+0.83%
BSFAF BSF Enterprise Plc
0.0584
0.00%
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
SCP.F Scancell Holdings plc
0.0825
-13.16%
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
99.49
+4.18%